133 related articles for article (PubMed ID: 26398662)
1. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M
Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662
[TBL] [Abstract][Full Text] [Related]
2. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
[TBL] [Abstract][Full Text] [Related]
3. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
Sládek NE; Kollander R; Sreerama L; Kiang DT
Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
Zhou Y; Wang Y; Ju X; Lan J; Zou H; Li S; Qi Y; Jia W; Hu J; Liang W; Zhang W; Pang L; Li F
Biomark Med; 2015; 9(8):777-90. PubMed ID: 26230297
[TBL] [Abstract][Full Text] [Related]
5. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
[TBL] [Abstract][Full Text] [Related]
6. Expression of C-myc and β-catenin and their correlation in triple negative breast cancer.
Wang J; Li M; Chen D; Nie J; Xi Y; Yang X; Chen Y; Yang Z
Minerva Med; 2017 Dec; 108(6):513-517. PubMed ID: 28889723
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.
Xu SL; Zeng DZ; Dong WG; Ding YQ; Rao J; Duan JJ; Liu Q; Yang J; Zhan N; Liu Y; Hu QP; Zhang X; Cui YH; Kung HF; Yu SC; Bian XW
Int J Clin Exp Pathol; 2014; 7(6):2976-86. PubMed ID: 25031716
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.
Khoury T; Ademuyiwa FO; Chandrasekhar R; Jabbour M; Deleo A; Ferrone S; Wang Y; Wang X
Mod Pathol; 2012 Mar; 25(3):388-97. PubMed ID: 22080062
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
[TBL] [Abstract][Full Text] [Related]
10. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
[TBL] [Abstract][Full Text] [Related]
11. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Yang W; Wang Y; Wang W; Chen Z; Bai G
Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
[TBL] [Abstract][Full Text] [Related]
12. Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
Sjöström M; Hartman L; Honeth G; Grabau D; Malmström P; Hegardt C; Fernö M; Niméus E
J Clin Pathol; 2015 Dec; 68(12):1012-9. PubMed ID: 26175266
[TBL] [Abstract][Full Text] [Related]
13. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
[TBL] [Abstract][Full Text] [Related]
14. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
Liu Y; Lv DL; Duan JJ; Xu SL; Zhang JF; Yang XJ; Zhang X; Cui YH; Bian XW; Yu SC
BMC Cancer; 2014 Jun; 14():444. PubMed ID: 24938375
[TBL] [Abstract][Full Text] [Related]
15. High ALDH1A1 expression indicates a poor prognosis in gastric neuroendocrine carcinoma.
Ye Y; Zhang S; Chen Y; Wang X; Wang P
Pathol Res Pract; 2018 Feb; 214(2):268-272. PubMed ID: 29103772
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.
Che J; Yang Y; Xiao J; Zhao P; Yan B; Dong S; Cao B
Tumour Biol; 2015 Aug; 36(8):6559-68. PubMed ID: 25820701
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wang K; Chen X; Zhan Y; Jiang W; Liu X; Wang X; Wu B
Med Oncol; 2013; 30(2):574. PubMed ID: 23585015
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
20. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
